Cutler Group’s GoodRx Holdings GDRX Stock Holding History

Cutler Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,100	Closed	-$1K	–	3861
2023 Q3	$1K	Buy	18,100 +900	+5%	+$6K	﹤0.01%	3509
2023 Q2	$1K	Sell	17,200 -7,000	-29%	-$37.7K	﹤0.01%	3271
2023 Q1	$6K	Buy	24,200 +17,800	+278%	+$99.2K	﹤0.01%	2624
2022 Q4	$1K	Sell	6,400 -45,100	-88%	-$222K	﹤0.01%	4007
2022 Q3	$1K	Buy	+51,500	New	+$325K	﹤0.01%	4532
2022 Q2	–	Sell	-24,200	Closed	-$31K	–	5209
2022 Q1	$31K	Buy	24,200 +12,000	+98%	+$275K	﹤0.01%	2666
2021 Q4	$5K	Sell	12,200 -40,300	-77%	-$1.62M	﹤0.01%	4178
2021 Q3	$154K	Buy	52,500 +20,500	+64%	+$744K	0.01%	1568
2021 Q2	$60K	Sell	32,000 -800	-2%	-$29.5K	﹤0.01%	2335
2021 Q1	$133K	Sell	32,800 -11,700	-26%	-$526K	0.01%	1551
2020 Q4	$172K	Buy	44,500 +22,300	+100%	+$1.02M	0.01%	1172
2020 Q3	$99K	Buy	+22,200	New	+$1.18M	0.01%	1330

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Cutler Group's GDRX Position: Q1 2024 in Review

Cutler Group reduced its GoodRx Holdings (GDRX) stake by 92% in Q1 2024, selling an estimated $4.19K and leaving 57 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Cutler Group first reported a position in GDRX in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.5M in Q1 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

Cutler Group held 57 shares of GoodRx Holdings worth $0 as of Q1 2024.
Cutler Group sold 633 GoodRx Holdings shares in Q1 2024, an estimated $4.19K.
GoodRx Holdings made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #2727 holding.
Cutler Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 14 quarters since.
Cutler Group's GoodRx Holdings position peaked at $1.5M in Q1 2021.
159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.